1 / 17

Inherited Bleeding Disorders Factor X Deficiency

Inherited Bleeding Disorders Factor X Deficiency. Galila Zaher, MRCPath Assistant Professor Consultant Hematologist KAUH. Stuart-Prower Deficiency. Inherited bleeding disorder. It is due : A lower than normal amount of FX or FX which does not work properly.

azriel
Download Presentation

Inherited Bleeding Disorders Factor X Deficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Inherited Bleeding DisordersFactor X Deficiency Galila Zaher, MRCPath Assistant Professor Consultant Hematologist KAUH

  2. Stuart-Prower Deficiency. • Inherited bleeding disorder. • It is due : • A lower than normal amount of FX • or FX which does not work properly. • Bleeding when the FX level below 10%

  3. Incidence • Rare factor deficiency. • Only 50 cases identified in the world. • 1 in 500,000 people. • More frequent :consanguinity • “Autosomal recessive" disorder. • Affects males and females equally • No known racial or ethnic predilection.

  4. Factor Level • More than 10% : Few problems • 1-10% :Mild to moderate bleeding • Less than 1% : Severe bleeding

  5. Clinical Presentation • Age: can present at any age. • More severe cases present during infancy • Umbilical cord stump bleeding • Bleeding after circumcision • Hemarthroses • Nose bleeds • Easy bruising • Bleeding in soft tissues and in muscles

  6. Clinical Presentation • Gastrointestinal bleeding • Heavy and prolonged menstrual period • Hematuria • Intracranial bleeding (rare) • First-trimester miscarriage &Post-partum bleeding • Post surgical traumatic bleeding • Petechiae, ecchymoses.

  7. Replacement Therapy • Fresh frozen plasma • Prothrombin Complex Concentrate

  8. Physiology • Vitamin K–dependent serine protease • First enzyme in the common pathway • Inherited or acquired. • In 1950s, Telfer reported woman named Prower 1956; Hougie reported man named Stuart 1957. • Factor designated Stuart-Prower .

  9. Clinical Features • Heterozygotes : asymptomatic. • Homozygous : hemorrhagic symptoms • Long arm ch 13, downstream FVII gene • It is composed of 8 exons • Signal region, a propeptide region, a glutamic acid domain, an ”aromatic stack” region, 2 regions homologous to epidermal growth factor, and a catalytic domain

  10. Physiology • FX Xa (intrinsic & extrinsic clotting cascades). • Activation by the :TF-F VIIa. • Or by :FIXa and F VIIIa. • FXa :Prothrombin  thrombin • Positive feedback loop by activating FV, VII, and VIII. • Inactivating both FVIII and tissue factor. • FXa is ultimately inactivated by AT

  11. Factor X Deficiency • Type I deficiency :reduced synthesis • Type II deficiency :production of a dysfunctional molecule • Complete absence is incompatible with life. • Missense mutations

  12. Several Specific Mutations • Gamma-carboxylation • Altering cleavage site of factor X • Interference with protein folding

  13. Acquired Deficiency • Vitamin K deficiency, Sodium valproate • Oral Anticoagulant • liver disease • Amyloidosis :8% • Myeloma • Mycoplasma pneumoniae infection ,URTI • Lupus anticoagulant • Leprosy • Children with severe burns • Topical thrombin administration • Leukemia and malignancy • intestinal malabsorption

  14. Lab Studies • PT, APTT • The Russell viper venom time cleaves FX FXa. • Type I : Functional & antigenic are decreased • Type II :functional is decreased and antigenic level varies • Vitamin K deficiency :other clotting factors reveal decreases

  15. Treatment • Factor X levels 10-40% is usually adequate. • Fresh frozen plasma • Initial dose :15-20 mL/kg • Maintenance doses of 3-6 mL/kg q 12-24 hours. • PCCs • Contains F II, VII, IX, and X and protein C. • Trace of heparin to guard against thrombosis. • Dose calculated depending on concentration of protein C • 50-125 U/kg • No more than 2-3 doses in the first 36-48 h • Thrombotic complications

  16. Acquired , treat underlying cause • Vitamin K :acquired deficiency • Amyloidosis :splenectomy

  17. Monitor • Thrombotic complications • Administered with rFVIIa, • OR antifibrinolytics • FX levels >50% • Hypersensitivity reaction • Clinical response • PT, and aPTT should be closely monitored • Vit K Adult Dose 10 mg PO/IV/IM/SC • Pediatric Dose :1 mg IM as single dose • IV :rare anaphylactoid reactions and death

More Related